The a2 Milk Company Limited
ACOPF
Other OTC4.90
USD
+0.30
- -
ISIN
NZATME0002S8
Return %
Stock
S&P500
1Y
-6.67
19.43
3Y
57.56
76.01
5Y
3.81
74.94
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- David L. Bortolussi
- Full Time Employees
- 511
- Sector
- Consumer Defensive
- Industry
- Packaged Foods
- Address
- 51 Shortland Street Auckland AUK New Zealand 1010
- IPO Date
- Apr 26, 2013
- Website
- thea2milkcompany.com
- Similar Companies
- Business
- The a2 Milk Company Limited The a2 Milk Company Limited (ACOPF) sells A2 protein-type branded milk and related nutritional products, including infant milk formula, fresh milk, and other dairy items containing only the A2 beta-casein protein type and no A1 protein; it manufactures and distributes these under the a2 Milk and a2 Platinum brands, with additional offerings in nutritional ingredients, rent, royalty, and licensing services. The company operates primarily in Australia, New Zealand, Greater China, North America, the United Kingdom, and emerging markets, targeting consumers seeking digestive-friendly dairy alternatives through supermarkets, convenience stores, pharmacies, and online channels. Founded in 2000 and headquartered in Auckland, New Zealand, with key facilities in McMahons Point, New South Wales, Australia, and Boulder, Colorado, United States, it focuses on premium functional foods in the dairy and infant nutrition segments. In recent developments, the company acquired Yashili New Zealand Dairy Co. Limited, including the Pōkeno manufacturing facility in New Zealand's Waikato region, from Yashili International Group Limited—a subsidiary of China Mengniu Dairy Group—for approximately NZ$282 million on a debt- and cash-free basis, with the transaction set to close around September 2025; this move supports expansion of China-label infant milk formula production, including ultra-premium organic variants with DHA and ARA, and includes plans for an additional NZ$100 million investment to boost capacity and create over 100 jobs. Concurrently, it divested its 75% stake in Mataura Valley Milk Limited, along with China Animal Husbandry Group's 25% holding, to Open Country Dairy Limited for net proceeds of about NZ$100 million after a NZ$130 million accounting loss, optimizing its manufacturing footprint while securing ongoing A1 protein-free ingredient supply via commercial agreement. These actions form part of a broader supply chain transformation strategy, contributing to a 21% rise in FY2025 net profit to NZ$202.9 million, driven by 10% growth in infant milk formula sales, particularly 17% in English-label products and 3.3% in China-label offerings.
The a2 Milk Company Limited (ACOPY) Q2 2026 Earnings Call Transcript
a2 Milk (OTCMKTS:ACOPF) Trading 8% Higher – Still a Buy?
The a2 Milk Company Limited (ACOPY) Shareholder/Analyst Call Transcript
The a2 Milk Company Limited (ACOPF) Q4 2025 Earnings Call Transcript
The a2 Milk Company: Multiple External And Internal Catalysts (Rating Upgrade)
The a2 Milk Company Limited (ACOPF) Q2 2025 Earnings Call Transcript
The a2 Milk Company Limited (ACOPF) Q4 2024 Earnings Call Transcript
The a2 Milk Company Limited (ACOPF) Q2 2024 Earnings Call Transcript
The a2 Milk Company Limited (ACOPF) Q4 2023 Earnings Call Transcript
The 7 Hottest Penny Stocks You Can Buy Today For A Rebound Tomorrow